secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xtant Medical Holdings, Inc. (XTNT)
CIK:        0001453593
Form:       8-K
Filed at:   2024-04-01T23:59:59+00:00
Accession:  0001493152-24-012143
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xtant Medical reports record FY 2023 revenue $91.3M, up 58% YoY; guides FY 2024 $112M-$116M
--------------------------------------------------------------------------------

- FY 2023 revenue $91.3M, +58% YoY; organic growth 15%.
- Net income $0.7M ($0.01/share) vs net loss $8.5M ($0.09) in 2022.
- Non-GAAP adjusted EBITDA $1.0M in 2023, compared to loss of $3.0M in 2022.
- FY 2024 revenue guidance $112M-$116M, representing 23%-27% growth.
- Gross margin improved 540 bps to 60.8% for 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453593/000149315224012143/0001493152-24-012143-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453593/000149315224012143/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-012143

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer